Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toru Nishiyama

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
The Prostate|January 4, 2024
Fewer systematic prostate core biopsies in clinical stage T1c prostate cancer leads to biochemical recurrence after brachytherapy as monotherapyYu Ozawa, Sunao Nohara, Ken Nakamura, et al.
Japanese Journal of Clinical Oncology|January 15, 2013
Comparison of preplanning and intraoperative planning for I-125 prostate brachytherapyKayo Yoshida, Toshio Ohashi, Atsunori Yorozu, et al.
Urology|September 6, 2005
Novel enhanced lung-colonizing variant of murine MBT-2 bladder cancer cellsMinoru Horinaga, Ryuichi Fukuyama, Toru Nishiyama, et al.
Brachytherapy|August 16, 2014
Permanent prostate brachytherapy with or without supplemental external beam radiotherapy as practiced in Japan: outcomes of 1300 patientsAtsunori Yorozu, Nobuko Kuroiwa, Akane Takahashi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 14, 2026
Prognostic Impact and Metastasis Propensity of Grade Group 5 Prostate Cancer Following Permanent Seed Implantation Brachytherapy-Based Trimodality Therapy: Implications for Intensified Staging and Systemic Therapy OptimizationTomomasa Matsuo, Yu Ozawa, Atsunori Yorozu, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2011
Dose constraint for minimizing grade 2 rectal bleeding following brachytherapy combined with external beam radiotherapy for localized prostate cancer: rectal dose-volume histogram analysis of 457 patientsYutaka Shiraishi, Atsunori Yorozu, Toshio Ohashi, et al.
International Journal of Clinical Oncology|October 31, 2013
Five-year potency preservation after iodine-125 prostate brachytherapyShuichi Nishimura, Atsunori Yorozu, Toshio Ohashi, et al.
Brachytherapy|March 1, 2016
Predictive factors for urinary toxicity after iodine-125 prostate brachytherapy with or without supplemental external beam radiotherapyTakahisa Eriguchi, Atsunori Yorozu, Nobuko Kuroiwa, et al.
Urology Case Reports|June 24, 2016
The Initial Case Report: Salvage Robotic Assisted Radical Prostatectomy After Heavy Ion RadiotherapyChoichiro Ozu, Keisuke Aoki, Ken Nakamura, et al.
Brachytherapy|June 25, 2018
Predictive factors of long-term rectal toxicity following permanent iodine-125 prostate brachytherapy with or without supplemental external beam radiation therapy in 2216 patientsTomoki Tanaka, Atsunori Yorozu, Shinya Sutani, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
The Prostate|January 4, 2024
Fewer systematic prostate core biopsies in clinical stage T1c prostate cancer leads to biochemical recurrence after brachytherapy as monotherapyYu Ozawa, Sunao Nohara, Ken Nakamura, et al.
Japanese Journal of Clinical Oncology|January 15, 2013
Comparison of preplanning and intraoperative planning for I-125 prostate brachytherapyKayo Yoshida, Toshio Ohashi, Atsunori Yorozu, et al.
Urology|September 6, 2005
Novel enhanced lung-colonizing variant of murine MBT-2 bladder cancer cellsMinoru Horinaga, Ryuichi Fukuyama, Toru Nishiyama, et al.
Brachytherapy|August 16, 2014
Permanent prostate brachytherapy with or without supplemental external beam radiotherapy as practiced in Japan: outcomes of 1300 patientsAtsunori Yorozu, Nobuko Kuroiwa, Akane Takahashi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 14, 2026
Prognostic Impact and Metastasis Propensity of Grade Group 5 Prostate Cancer Following Permanent Seed Implantation Brachytherapy-Based Trimodality Therapy: Implications for Intensified Staging and Systemic Therapy OptimizationTomomasa Matsuo, Yu Ozawa, Atsunori Yorozu, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2011
Dose constraint for minimizing grade 2 rectal bleeding following brachytherapy combined with external beam radiotherapy for localized prostate cancer: rectal dose-volume histogram analysis of 457 patientsYutaka Shiraishi, Atsunori Yorozu, Toshio Ohashi, et al.
International Journal of Clinical Oncology|October 31, 2013
Five-year potency preservation after iodine-125 prostate brachytherapyShuichi Nishimura, Atsunori Yorozu, Toshio Ohashi, et al.
Brachytherapy|March 1, 2016
Predictive factors for urinary toxicity after iodine-125 prostate brachytherapy with or without supplemental external beam radiotherapyTakahisa Eriguchi, Atsunori Yorozu, Nobuko Kuroiwa, et al.
Urology Case Reports|June 24, 2016
The Initial Case Report: Salvage Robotic Assisted Radical Prostatectomy After Heavy Ion RadiotherapyChoichiro Ozu, Keisuke Aoki, Ken Nakamura, et al.
Brachytherapy|June 25, 2018
Predictive factors of long-term rectal toxicity following permanent iodine-125 prostate brachytherapy with or without supplemental external beam radiation therapy in 2216 patientsTomoki Tanaka, Atsunori Yorozu, Shinya Sutani, et al.
Pageof 4